FAPI PET/CT guided dose optimization and translational study for bone and soft tissue sarcoma

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036569

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue sarcoma

Interventions

carbon ion therapy group:carbon ion

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1)Pathology conformed unresectable bone and soft tissue sarcoma by surgeon evaluated,Or bone and soft tissue sarcoma who reject surgery; 2) Excluded regional lymph nodes or distant metastasis; 3) Age 14~70 years.

Exclusion criteria

Exclusion criteria: 1)With egional lymph nodes or distant metastasis; 2)The treatment area received radiation therapy; 3)Pregnant woman.

Design outcomes

Secondary

Measure	Time frame
2 years overall survival;Acute and late toxicity;	—

Primary

Measure	Time frame
2 years local control;	—

Countries

China

Contacts

Public ContactZhangqing

Shanghai Proton and Heavy Ion Center

qing.zhang@sphic.org.cn+86 13917374609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026